Reyvow vs. Aimovig

Reviewed on 10/28/2019

Are Reyvow and Aimovig the Same Thing?

Reyvow (lasmiditan) and Aimovig (erenumab-aooe) Injection are used to prevent or treat migraine.

Reyvow is used for the acute treatment of migraine with or without aura in adults. Reyvow is not indicated for the preventive treatment of migraine.

Aimovig is indicated for the preventive treatment of migraine in adults.

Reyvow and Aimovig belong to different drug classes. Reyvow is a serotonin (5-HT) 1F receptor agonist and Aimovig is a calcitonin gene-related peptide receptor antagonist.

Side effects of Reyvow that are different from Aimovig include dizziness, fatigue, numbness and tingling, sedation, nausea, and vomiting.

Side effects of Aimovig that are different from Reyvow include injection site reactions (pain or redness), constipation, and muscle spasms or cramps.

Reyvow may interact with alcohol or other CNS depressants, antidepressants, MAO inhibitors, trazodone, dextromethorphan, St. John's wort, medications that lower heart rate, and P-gp or BCRP substrates.

Aimovig may interact with other drugs.

What Are Possible Side Effects of Reyvow?

Common side effects of Reyvow include:

  • dizziness,
  • fatigue,
  • numbness and tingling,
  • sedation,
  • nausea, and
  • vomiting

What Are Possible Side Effects of Aimovig?

Common side effects of Aimovig include:

  • injection site reactions (pain or redness),
  • constipation, and
  • muscle spasms or
  • cramps

What Is Reyvow?

Reyvow (lasmiditan) is a serotonin (5-HT) 1F receptor agonist indicated for the acute treatment of migraine with or without aura in adults. Reyvow is not indicated for the preventive treatment of migraine.

What Is Aimovig?

Aimovig (erenumab-aooe) Injection is a calcitonin gene-related peptide receptor antagonist indicated for the preventive treatment of migraine in adults.

QUESTION

Who suffers more frequently from migraine headaches? See Answer

What Drugs Interact With Reyvow?

Reyvow may interact with:

  • alcohol or other CNS depressants,
  • antidepressants,
  • MAO inhibitors,
  • trazodone,
  • dextromethorphan,
  • St. John's wort,
  • medications that lower heart rate, and
  • P-gp or BCRP substrates

What Drugs Interact With Aimovig?

Aimovig may interact with other drugs. Tell your doctor all medications and supplements you use.

How Should Reyvow Be Taken?

The recommended dose of Reyvow is 50 mg, 100 mg, or 200 mg taken orally, as needed. No more than one dose of Reyvow should be taken in 24 hours.

How Should Aimovig Be Taken?

The recommended dosage of Aimovig is 70 mg once monthly; some patients may benefit from a dosage of 140 mg once monthly, which is administered as two consecutive subcutaneous injections of 70 mg each.

SLIDESHOW

16 Surprising Headache Triggers and Tips for Pain Relief See Slideshow
Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

References
Lilly. Reyvow Drug Information.

https://investor.lilly.com/news-releases/news-release-details/lillys-reyvowtm-lasmiditan-first-and-only-medicine-new-class

Amgen. Aimovig Product Information.

https://www.aimovig.com

Health Solutions From Our Sponsors